The orexin story and orexin receptor antagonists for the treatment of insomnia.

Author: DingemanseJasper, MuehlanClemens, RochCatherine, VaillantCedric

Paper Details 
Original Abstract of the Article :
Insomnia is present in up to one third of the adult population worldwide, and it can present independently or with other medical conditions such as mental, metabolic, or cardiovascular diseases, which highlights the importance of treating this multifaceted disorder. Insomnia is associated with an ab...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jsr.13902

データ提供:米国国立医学図書館(NLM)

Orexin Receptor Antagonists for Insomnia: A Desert of Restlessness

Insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep, is a common condition that can disrupt the tranquility of our lives. This research explores the role of orexin, a neurotransmitter involved in wakefulness, in the development of insomnia. The study examines the potential of orexin receptor antagonists as a new therapeutic approach for treating insomnia, aiming to understand how blocking orexin signaling could improve sleep quality and reduce insomnia symptoms.

Orexin Receptor Antagonists: A New Oasis in the Desert of Insomnia

The study highlights the potential of orexin receptor antagonists to offer a novel approach for treating insomnia. These drugs work by blocking the orexin pathway, which is involved in promoting wakefulness, leading to improved sleep quality and reduced insomnia symptoms. The study suggests that orexin receptor antagonists may be a viable option for long-term treatment of insomnia, as they do not appear to induce dependence or tolerance, unlike some traditional sleep medications.

Navigating the Desert of Insomnia: A New Path to Restful Sleep

This research opens a new path in the desert of insomnia, offering a promising therapeutic approach with orexin receptor antagonists. The study emphasizes the importance of exploring innovative treatments for insomnia, focusing on alternative mechanisms of action that can address the underlying causes of sleep disturbances.

Dr. Camel's Conclusion

The desert of insomnia can be a challenging and exhausting landscape, leaving many yearning for restful sleep. This research provides a glimmer of hope, highlighting the potential of orexin receptor antagonists to offer a new oasis in the desert of insomnia. By exploring new pathways and innovative therapies, we can continue to navigate the desert of sleep disturbances, seeking solutions to improve sleep quality and promote a more restful and fulfilling life.

Date :
  1. Date Completed 2023-11-30
  2. Date Revised 2023-11-30
Further Info :

Pubmed ID

37086045

DOI: Digital Object Identifier

10.1111/jsr.13902

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.